수의용 POC(Point of Care) 진단 시장 예측(2026-2032년)

The Veterinary Point Of Care Diagnostics Market is projected to grow by USD 5.13 billion at a CAGR of 12.87% by 2032.

Veterinary point of care diagnostics refers to rapid, near-patient testing performed in clinics, farms, shelters, equine facilities, and mobile veterinary settings to support timely clinical decisions for companion animals and livestock. The category includes immunoassays, hematology and clinical chemistry analyzers, molecular tests, urinalysis, blood gas and electrolyte systems, parasite screening, infectious disease testing, and emerging connected diagnostic platforms. Demand is being shaped by rising pet ownership, higher expectations for animal healthcare, increased awareness of zoonotic and foodborne diseases, and the need for faster treatment decisions in decentralized care environments. In companion animal medicine, point of care testing helps veterinarians evaluate acute illness, monitor chronic conditions, guide antimicrobial decisions, and improve client communication during a single visit. In livestock and production animal health, rapid diagnostics support herd management, biosecurity, outbreak containment, and responsible use of medicines. The veterinary diagnostics landscape is also being influenced by One Health priorities, as animal disease surveillance is increasingly linked with public health, food security, and antimicrobial resistance management. As practices seek faster turnaround times, improved diagnostic confidence, and workflow efficiency, veterinary point of care diagnostics is becoming a critical enabler of preventive care, precision treatment, and operational resilience across animal health systems.

Transformative Shifts Reshaping Veterinary Diagnostics

The veterinary point of care diagnostics landscape is undergoing transformative shifts driven by the convergence of digital connectivity, miniaturized instruments, molecular testing, and broader preventive care models. Veterinary practices are moving from reactive testing toward earlier disease detection, routine wellness screening, and longitudinal monitoring of chronic conditions such as kidney disease, endocrine disorders, inflammatory conditions, and infectious diseases. Portable analyzers and cartridge-based systems are reducing dependence on centralized laboratories for time-sensitive decisions, while cloud-connected platforms are improving record integration, quality control, and test result accessibility. In livestock health, rapid testing is becoming more important for farm-level biosecurity, reproductive management, respiratory disease control, mastitis screening, and surveillance of transboundary animal diseases. Regulatory and public health emphasis on antimicrobial stewardship is also increasing the value of diagnostics that help distinguish bacterial, viral, parasitic, and inflammatory causes of disease before treatment is initiated. At the same time, veterinary teams are facing staffing shortages and rising caseload complexity, making easy-to-use, automated, and low-maintenance diagnostic systems especially valuable. The strongest structural shift is the movement toward integrated diagnostic ecosystems that combine point of care testing, electronic medical records, telehealth support, and data-driven clinical decision-making.

Cumulative Impact of Artificial Intelligence on Veterinary Diagnostics

Artificial intelligence is creating a cumulative impact across veterinary point of care diagnostics by improving interpretation, workflow automation, image recognition, predictive analytics, and clinical decision support. AI-enabled diagnostic tools can support pattern recognition in cytology, hematology, urinalysis sediment analysis, radiology-adjacent workflows, and digital microscopy, helping veterinary professionals triage abnormal findings more consistently. In point of care environments, AI can reduce manual interpretation variability, flag quality-control issues, and assist clinicians in connecting test results with patient history, breed, age, clinical signs, and treatment response. Machine learning models are also being explored for early detection of disease patterns across animal populations, including herd-level health monitoring, outbreak signals, and antimicrobial resistance trends. The technology is particularly relevant where veterinary expertise is unevenly distributed, as AI-supported platforms can extend decision support to rural clinics, farm settings, shelters, and mobile units. However, adoption requires validated datasets, transparent algorithms, cybersecurity controls, regulatory clarity, and clinician oversight. The most practical near-term role of AI is not replacing veterinary judgment, but accelerating routine interpretation, improving consistency, strengthening surveillance, and enabling more proactive animal health management.

Key Regional Insights Across Veterinary Point of Care Diagnostics

Asia-Pacific is advancing rapidly as veterinary point of care diagnostics gains relevance across companion animal clinics, poultry and swine production, dairy operations, and aquaculture health programs. Urban pet ownership, expanding veterinary infrastructure, and government attention to animal disease surveillance are supporting adoption in China, India, Japan, South Korea, and Australia, while regional livestock density keeps infectious disease monitoring and farm-level testing central to public health and food security priorities. North America demonstrates mature clinical adoption, supported by a large companion animal healthcare base, advanced veterinary hospital networks, growing pet insurance penetration in selected settings, and strong interest in antimicrobial stewardship and chronic disease monitoring. Latin America is shaped by a dual demand profile, with growing companion animal care in urban centers and persistent need for livestock diagnostics in cattle, poultry, and swine systems, particularly where rapid testing supports export compliance, herd health, and zoonotic disease control. Europe emphasizes regulated animal health practices, food safety, animal welfare standards, and antimicrobial reduction policies, all of which strengthen the case for diagnostic-led treatment decisions in both clinics and production settings. The Middle East is seeing gradual adoption through premium companion animal care, equine medicine, falconry-related veterinary services, and investments in food security and livestock disease control. Africa presents an important need-based opportunity, as point of care testing can support surveillance of zoonotic diseases, livestock productivity, and rural veterinary access, although infrastructure gaps, affordability constraints, and supply chain consistency remain critical adoption barriers.

Key Group Insights Influencing Veterinary Diagnostic Adoption

ASEAN markets are characterized by a combination of rising urban pet care expenditure, expanding poultry and aquaculture industries, and heightened attention to transboundary animal diseases, making rapid, accessible diagnostics increasingly relevant for both clinic-based and field-based use. The GCC is developing demand through high-value companion animal services, equine and camel health, and national food security programs that require stronger livestock health monitoring and biosecurity capabilities. The European Union provides one of the most policy-driven environments for veterinary point of care diagnostics, with animal welfare rules, food safety systems, and antimicrobial resistance strategies encouraging evidence-based prescribing and systematic disease surveillance. BRICS countries represent diverse but significant diagnostic needs, ranging from large companion animal populations and expanding private veterinary care to intensive livestock systems that require cost-effective infectious disease detection and herd health management. G7 markets generally show advanced adoption conditions, including established veterinary infrastructure, higher acceptance of in-clinic testing, greater use of digital health records, and strong emphasis on preventive care. NATO countries, while not a healthcare market bloc, include many nations with advanced veterinary public health systems, defense-related animal health programs, and biosecurity priorities, reinforcing the importance of rapid diagnostics in outbreak preparedness, working animal health, and cross-border disease monitoring.

Key Country Insights Shaping Veterinary Point of Care Diagnostics

The United States remains a key adopter of veterinary point of care diagnostics due to its extensive companion animal care network, strong specialty and emergency veterinary services, and growing focus on preventive screening and chronic disease monitoring. Canada shows steady demand linked to companion animal care, livestock health, and antimicrobial stewardship, with regional needs spanning urban practices, dairy operations, and remote veterinary access. Mexico is influenced by expanding pet care services and livestock disease management requirements, particularly in cattle, poultry, and swine production. Brazil combines one of the world's major livestock sectors with rising companion animal healthcare expectations, making rapid diagnostics relevant for both farm productivity and urban clinic workflows. The United Kingdom emphasizes companion animal wellness, equine care, laboratory-quality clinical standards, and responsible antimicrobial prescribing, all supporting diagnostic-led veterinary decision-making. Germany benefits from advanced veterinary infrastructure, strong livestock production standards, and strict animal health oversight, while France shows demand across companion animal medicine, food animal health, and national surveillance frameworks. Russia's veterinary point of care needs are shaped by large geography, livestock production, and the value of decentralized testing in areas with limited laboratory access. Italy and Spain are supported by established small animal practices, livestock systems, and interest in infectious disease control, including vector-borne and parasitic conditions in warmer regions. China is expanding adoption through pet healthcare growth, modernization of veterinary services, and large-scale livestock and aquaculture disease management. India has substantial need for affordable, portable diagnostics across dairy, poultry, companion animals, and rural veterinary services. Japan demonstrates high standards in companion animal medicine and aging pet care, favoring diagnostics that support chronic disease management and rapid clinical decisions. Australia places strong emphasis on biosecurity, livestock health, equine medicine, companion animal care, and disease surveillance across geographically dispersed settings. South Korea is supported by rising pet ownership, advanced urban veterinary clinics, and increasing use of in-clinic diagnostic technologies.

Actionable Recommendations for Veterinary Diagnostic Leaders

Industry leaders should prioritize diagnostic platforms that deliver accuracy, speed, usability, and connectivity while fitting the real-world workflow of veterinary teams. Product strategies should focus on compact analyzers, multiplex testing, easy sample preparation, clear result interpretation, and integration with practice management systems. In companion animal care, leaders should align offerings with wellness testing, emergency triage, chronic disease monitoring, infectious disease panels, and client-facing communication tools that improve treatment acceptance. In livestock and field settings, emphasis should be placed on rugged portability, low maintenance, temperature-tolerant consumables, and cost-effective tests that support biosecurity, herd health, and antimicrobial stewardship. Commercial teams should adapt go-to-market models by region, recognizing that high-income urban clinics may prioritize advanced connectivity and broad test menus, while rural and production settings may prioritize affordability, durability, and training support. Evidence generation is essential; suppliers should invest in clinical validation, species-specific performance data, quality-control protocols, and education that helps veterinarians interpret results responsibly. Partnerships with veterinary schools, public health agencies, livestock organizations, shelters, and digital health providers can accelerate responsible adoption. Leaders should also prepare for AI-enabled diagnostics by strengthening data governance, cybersecurity, algorithm validation, and transparent clinical decision support frameworks.

Research Methodology for Veterinary Point of Care Diagnostic Analysis

This executive summary is developed through a structured secondary research approach focused on verified and data-backed industry evidence from animal health authorities, veterinary associations, peer-reviewed literature, regulatory sources, public health organizations, academic publications, and recognized government datasets. The methodology evaluates demand drivers across companion animal care, livestock health, zoonotic disease surveillance, antimicrobial stewardship, veterinary workforce trends, and diagnostic technology adoption. Regional, group, and country insights are assessed by examining veterinary infrastructure maturity, animal population dynamics, livestock production relevance, biosecurity priorities, pet healthcare trends, regulatory environments, and access to diagnostic services. The research framework emphasizes qualitative validation rather than market sizing or forecasting, ensuring that the analysis remains grounded in observed industry developments and documented healthcare needs. Technology trends are reviewed across immunodiagnostics, clinical chemistry, hematology, molecular diagnostics, digital microscopy, connected analyzers, and AI-supported interpretation. Insights are synthesized to identify practical implications for veterinary clinics, animal health providers, diagnostic developers, livestock stakeholders, and public health decision-makers. All conclusions are framed to support strategic planning without relying on speculative market estimates, share calculations, or forward-looking revenue projections.

Conclusion: Strategic Role of Veterinary Point of Care Diagnostics

Veterinary point of care diagnostics is becoming an essential component of modern animal healthcare as veterinarians, livestock producers, and public health stakeholders seek faster, more reliable, and more accessible diagnostic answers. The sector is being strengthened by preventive care trends, antimicrobial stewardship, zoonotic disease surveillance, chronic disease monitoring, and the modernization of veterinary workflows. Regional adoption varies according to veterinary infrastructure, animal health priorities, affordability, regulation, and biosecurity needs, but the underlying direction is consistent: rapid in-clinic and field-based diagnostics are moving closer to the center of clinical and population-level decision-making. Artificial intelligence, connectivity, and automation can improve diagnostic consistency and workflow efficiency when deployed with proper validation and veterinary oversight. For industry leaders, the most durable opportunities lie in clinically validated, user-friendly, connected, and context-specific solutions that support both companion animal medicine and production animal health. By aligning innovation with real-world veterinary needs, point of care diagnostics can improve treatment decisions, strengthen surveillance, reduce inappropriate antimicrobial use, and enhance animal welfare across global markets.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Point Of Care Diagnostics Market, by Product Type

• 7.1. Introduction
• 7.2. Instruments & Analyzers
• 7.3. Consumables & Reagents
• 7.4. Rapid Test Kits

8. Veterinary Point Of Care Diagnostics Market, by Animal Type

• 8.1. Introduction
• 8.2. Companion Animals
  • 8.2.1. Cats
  • 8.2.2. Dogs
• 8.3. Livestock
  • 8.3.1. Cattle
  • 8.3.2. Horses
  • 8.3.3. Poultry
  • 8.3.4. Swine

9. Veterinary Point Of Care Diagnostics Market, by Diagnostic Test Type

• 9.1. Introduction
• 9.2. Clinical Biochemistry
• 9.3. Hematology
• 9.4. Immunodiagnostics
• 9.5. Molecular Diagnostics
• 9.6. Urinalysis

10. Veterinary Point Of Care Diagnostics Market, by Technology

• 10.1. Introduction
• 10.2. ELISA
• 10.3. Lateral Flow Assay
• 10.4. PCR
• 10.5. Microfluidics

11. Veterinary Point Of Care Diagnostics Market, by Sample Type

• 11.1. Introduction
• 11.2. Blood
• 11.3. Feces
• 11.4. Milk
• 11.5. Saliva
• 11.6. Urine

12. Veterinary Point Of Care Diagnostics Market, by Application

• 12.1. Introduction
• 12.2. Infectious Disease Testing
• 12.3. Clinical Pathology
• 12.4. Endocrinology
• 12.5. Parasitology
• 12.6. Metabolic Disorders

13. Veterinary Point Of Care Diagnostics Market, by End User

• 13.1. Introduction
• 13.2. Veterinary Hospitals & Clinics
• 13.3. Veterinary Diagnostic Laboratories
• 13.4. Research Institutes
• 13.5. Livestock Farms & Facilities

14. Veterinary Point Of Care Diagnostics Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Veterinary Point Of Care Diagnostics Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Veterinary Point Of Care Diagnostics Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Share Analysis, 2025
• 17.2. FPNV Positioning Matrix, 2025
• 17.3. Market Concentration Analysis, 2025
  • 17.3.1. Concentration Ratio (CR)
  • 17.3.2. Herfindahl Hirschman Index (HHI)
• 17.4. Recent Developments & Impact Analysis, 2025
• 17.5. Product Portfolio Analysis, 2025
• 17.6. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Agrolabo Spa
• 18.2. Antech Diagnostics, Inc. by Mars, Incorporated
• 18.3. B. Braun SE
• 18.4. Biogal Galed Labs
• 18.5. BioMerieux SA
• 18.6. BioNote, Inc.
• 18.7. Chembio Diagnostic Systems, Inc. by Biosynex
• 18.8. Dispomed Ltd.
• 18.9. Esaote SpA
• 18.10. Eurolyser Diagnostica GmbH
• 18.11. Fassisi GmbH
• 18.12. FUJIFILM Holdings Corporation
• 18.13. Getein Biotech, Inc.
• 18.14. IDEXX Laboratories, Inc.
• 18.15. Medtronic PLC
• 18.16. Mindray Medical International Limited
• 18.17. Neogen Corporation
• 18.18. Nova Biomedical Corporation
• 18.19. Precision Biosensor Inc.
• 18.20. QIAGEN N.V.
• 18.21. Randox Laboratories Ltd.
• 18.22. Shenzhen Mindray Animal Medical Technology Co., Ltd.
• 18.23. Thermo Fisher Scientific Inc.
• 18.24. Vimian Group AB
• 18.25. Virbac Corporation
• 18.26. Woodley Equipment Company Inc.
• 18.27. Zoetis Inc.